Table of Content

1 Bio-pharma Market Overview
1.1 Bio-pharma Product Scope
1.2 Bio-pharma Segment by Type
1.2.1 Global Bio-pharma Sales by Type (2016 & 2021 & 2027)
1.2.2 Monoclonal Antibodies
1.2.3 Recombinant Proteins
1.2.4 Granulocyte-Colony Stimulating Factor (G-CSF)
1.2.5 Interferons
1.2.6 Recombinant Human Insulin
1.2.7 Erythropoietin
1.2.8 Vaccines
1.2.9 Growth Hormones
1.2.10 Purified Proteins
1.2.11 Others
1.3 Bio-pharma Segment by Application
1.3.1 Global Bio-pharma Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Metabolic Disorders
1.3.3 Oncology
1.3.4 Neurological Disorders
1.3.5 Cardiovascular Diseases
1.3.6 Inflammatory and Infectious Diseases
1.3.7 Others
1.4 Bio-pharma Market Estimates and Forecasts (2016-2027)
1.4.1 Global Bio-pharma Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Bio-pharma Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Bio-pharma Price Trends (2016-2027)

2 Bio-pharma Estimates and Forecasts by Region
2.1 Global Bio-pharma Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Bio-pharma Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Bio-pharma Sales Market Share by Region (2016-2021)
2.2.2 Global Bio-pharma Revenue Market Share by Region (2016-2021)
2.3 Global Bio-pharma Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Bio-pharma Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Bio-pharma Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Bio-pharma Estimates and Projections (2016-2027)
2.4.2 Europe Bio-pharma Estimates and Projections (2016-2027)
2.4.3 China Bio-pharma Estimates and Projections (2016-2027)
2.4.4 Japan Bio-pharma Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Bio-pharma Estimates and Projections (2016-2027)
2.4.6 India Bio-pharma Estimates and Projections (2016-2027)

3 Global Bio-pharma Competition Landscape by Players
3.1 Global Top Bio-pharma Players by Sales (2016-2021)
3.2 Global Top Bio-pharma Players by Revenue (2016-2021)
3.3 Global Bio-pharma Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bio-pharma as of 2020)
3.4 Global Bio-pharma Average Price by Company (2016-2021)
3.5 Manufacturers Bio-pharma Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Bio-pharma Market Size by Type
4.1 Global Bio-pharma Historic Market Review by Type (2016-2021)
4.1.1 Global Bio-pharma Sales Market Share by Type (2016-2021)
4.1.2 Global Bio-pharma Revenue Market Share by Type (2016-2021)
4.1.3 Global Bio-pharma Price by Type (2016-2021)
4.2 Global Bio-pharma Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Bio-pharma Sales Forecast by Type (2022-2027)
4.2.2 Global Bio-pharma Revenue Forecast by Type (2022-2027)
4.2.3 Global Bio-pharma Price Forecast by Type (2022-2027)

5 Global Bio-pharma Market Size by Application
5.1 Global Bio-pharma Historic Market Review by Application (2016-2021)
5.1.1 Global Bio-pharma Sales Market Share by Application (2016-2021)
5.1.2 Global Bio-pharma Revenue Market Share by Application (2016-2021)
5.1.3 Global Bio-pharma Price by Application (2016-2021)
5.2 Global Bio-pharma Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Bio-pharma Sales Forecast by Application (2022-2027)
5.2.2 Global Bio-pharma Revenue Forecast by Application (2022-2027)
5.2.3 Global Bio-pharma Price Forecast by Application (2022-2027)

6 North America Bio-pharma Market Facts & Figures
6.1 North America Bio-pharma Sales by Company
6.1.1 North America Bio-pharma Sales by Company (2016-2021)
6.1.2 North America Bio-pharma Revenue by Company (2016-2021)
6.2 North America Bio-pharma Sales Breakdown by Type
6.2.1 North America Bio-pharma Sales Breakdown by Type (2016-2021)
6.2.2 North America Bio-pharma Sales Breakdown by Type (2022-2027)
6.3 North America Bio-pharma Sales Breakdown by Application
6.3.1 North America Bio-pharma Sales Breakdown by Application (2016-2021)
6.3.2 North America Bio-pharma Sales Breakdown by Application (2022-2027)

7 Europe Bio-pharma Market Facts & Figures
7.1 Europe Bio-pharma Sales by Company
7.1.1 Europe Bio-pharma Sales by Company (2016-2021)
7.1.2 Europe Bio-pharma Revenue by Company (2016-2021)
7.2 Europe Bio-pharma Sales Breakdown by Type
7.2.1 Europe Bio-pharma Sales Breakdown by Type (2016-2021)
7.2.2 Europe Bio-pharma Sales Breakdown by Type (2022-2027)
7.3 Europe Bio-pharma Sales Breakdown by Application
7.3.1 Europe 133 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 133 Sales Breakdown by Application (2022-2027)

8 China Bio-pharma Market Facts & Figures
8.1 China Bio-pharma Sales by Company
8.1.1 China Bio-pharma Sales by Company (2016-2021)
8.1.2 China Bio-pharma Revenue by Company (2016-2021)
8.2 China Bio-pharma Sales Breakdown by Type
8.2.1 China Bio-pharma Sales Breakdown by Type (2016-2021)
8.2.2 China Bio-pharma Sales Breakdown by Type (2022-2027)
8.3 China Bio-pharma Sales Breakdown by Application
8.3.1 China 155 Sales Breakdown by Application (2016-2021)
8.3.2 China 155 Sales Breakdown by Application (2022-2027)

9 Japan Bio-pharma Market Facts & Figures
9.1 Japan Bio-pharma Sales by Company
9.1.1 Japan Bio-pharma Sales by Company (2016-2021)
9.1.2 Japan Bio-pharma Revenue by Company (2016-2021)
9.2 Japan Bio-pharma Sales Breakdown by Type
9.2.1 Japan Bio-pharma Sales Breakdown by Type (2016-2021)
9.2.2 Japan Bio-pharma Sales Breakdown by Type (2022-2027)
9.3 Japan Bio-pharma Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Bio-pharma Market Facts & Figures
10.1 Southeast Asia Bio-pharma Sales by Company
10.1.1 Southeast Asia Bio-pharma Sales by Company (2016-2021)
10.1.2 Southeast Asia Bio-pharma Revenue by Company (2016-2021)
10.2 Southeast Asia Bio-pharma Sales Breakdown by Type
10.2.1 Southeast Asia Bio-pharma Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Bio-pharma Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Bio-pharma Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Bio-pharma Market Facts & Figures
11.1 India Bio-pharma Sales by Company
11.1.1 India Bio-pharma Sales by Company (2016-2021)
11.1.2 India Bio-pharma Revenue by Company (2016-2021)
11.2 India Bio-pharma Sales Breakdown by Type
11.2.1 India Bio-pharma Sales Breakdown by Type (2016-2021)
11.2.2 India Bio-pharma Sales Breakdown by Type (2022-2027)
11.3 India Bio-pharma Sales Breakdown by Application
11.3.1 India Bio-pharma Sales Breakdown by Application (2016-2021)
11.3.2 India Bio-pharma Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Bio-pharma Business
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Business Overview
12.1.3 Pfizer Bio-pharma Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer Bio-pharma Products Offered
12.1.5 Pfizer Recent Development
12.2 F. Hoffmann-La Roche AG
12.2.1 F. Hoffmann-La Roche AG Corporation Information
12.2.2 F. Hoffmann-La Roche AG Business Overview
12.2.3 F. Hoffmann-La Roche AG Bio-pharma Sales, Revenue and Gross Margin (2016-2021)
12.2.4 F. Hoffmann-La Roche AG Bio-pharma Products Offered
12.2.5 F. Hoffmann-La Roche AG Recent Development
12.3 Johnson & Johnson Services
12.3.1 Johnson & Johnson Services Corporation Information
12.3.2 Johnson & Johnson Services Business Overview
12.3.3 Johnson & Johnson Services Bio-pharma Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Johnson & Johnson Services Bio-pharma Products Offered
12.3.5 Johnson & Johnson Services Recent Development
12.4 Sanofi, Amgen
12.4.1 Sanofi, Amgen Corporation Information
12.4.2 Sanofi, Amgen Business Overview
12.4.3 Sanofi, Amgen Bio-pharma Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sanofi, Amgen Bio-pharma Products Offered
12.4.5 Sanofi, Amgen Recent Development
12.5 AbbVie
12.5.1 AbbVie Corporation Information
12.5.2 AbbVie Business Overview
12.5.3 AbbVie Bio-pharma Sales, Revenue and Gross Margin (2016-2021)
12.5.4 AbbVie Bio-pharma Products Offered
12.5.5 AbbVie Recent Development
12.6 Merck & Co., Inc
12.6.1 Merck & Co., Inc Corporation Information
12.6.2 Merck & Co., Inc Business Overview
12.6.3 Merck & Co., Inc Bio-pharma Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Merck & Co., Inc Bio-pharma Products Offered
12.6.5 Merck & Co., Inc Recent Development
12.7 Biogen Idec
12.7.1 Biogen Idec Corporation Information
12.7.2 Biogen Idec Business Overview
12.7.3 Biogen Idec Bio-pharma Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Biogen Idec Bio-pharma Products Offered
12.7.5 Biogen Idec Recent Development
12.8 Bayer AG
12.8.1 Bayer AG Corporation Information
12.8.2 Bayer AG Business Overview
12.8.3 Bayer AG Bio-pharma Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Bayer AG Bio-pharma Products Offered
12.8.5 Bayer AG Recent Development
12.9 Eli Lilly and Company
12.9.1 Eli Lilly and Company Corporation Information
12.9.2 Eli Lilly and Company Business Overview
12.9.3 Eli Lilly and Company Bio-pharma Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Eli Lilly and Company Bio-pharma Products Offered
12.9.5 Eli Lilly and Company Recent Development
12.10 Novartis AG GlaxoSmithKline Plc
12.10.1 Novartis AG GlaxoSmithKline Plc Corporation Information
12.10.2 Novartis AG GlaxoSmithKline Plc Business Overview
12.10.3 Novartis AG GlaxoSmithKline Plc Bio-pharma Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Novartis AG GlaxoSmithKline Plc Bio-pharma Products Offered
12.10.5 Novartis AG GlaxoSmithKline Plc Recent Development
12.11 Bristol-Myers Squibb Company
12.11.1 Bristol-Myers Squibb Company Corporation Information
12.11.2 Bristol-Myers Squibb Company Business Overview
12.11.3 Bristol-Myers Squibb Company Bio-pharma Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Bristol-Myers Squibb Company Bio-pharma Products Offered
12.11.5 Bristol-Myers Squibb Company Recent Development
12.12 AstraZeneca PLC
12.12.1 AstraZeneca PLC Corporation Information
12.12.2 AstraZeneca PLC Business Overview
12.12.3 AstraZeneca PLC Bio-pharma Sales, Revenue and Gross Margin (2016-2021)
12.12.4 AstraZeneca PLC Bio-pharma Products Offered
12.12.5 AstraZeneca PLC Recent Development
12.13 Abbott Laboratories
12.13.1 Abbott Laboratories Corporation Information
12.13.2 Abbott Laboratories Business Overview
12.13.3 Abbott Laboratories Bio-pharma Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Abbott Laboratories Bio-pharma Products Offered
12.13.5 Abbott Laboratories Recent Development

13 Bio-pharma Manufacturing Cost Analysis
13.1 Bio-pharma Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Bio-pharma
13.4 Bio-pharma Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Bio-pharma Distributors List
14.3 Bio-pharma Customers

15 Market Dynamics
15.1 Bio-pharma Market Trends
15.2 Bio-pharma Drivers
15.3 Bio-pharma Market Challenges
15.4 Bio-pharma Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Bio-pharma Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Bio-pharma Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Bio-pharma Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Bio-pharma Sales (K Pcs) by Region (2016-2021)
Table 5. Global Bio-pharma Sales Market Share by Region (2016-2021)
Table 6. Global Bio-pharma Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Bio-pharma Revenue Share by Region (2016-2021)
Table 8. Global Bio-pharma Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Bio-pharma Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Bio-pharma Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Bio-pharma Revenue Share Forecast by Region (2022-2027)
Table 12. Global Bio-pharma Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Bio-pharma Sales Share by Company (2016-2021)
Table 14. Global Bio-pharma Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Bio-pharma Revenue Share by Company (2016-2021)
Table 16. Global Bio-pharma by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bio-pharma as of 2020)
Table 17. Global Bio-pharma Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Bio-pharma Manufacturing Sites and Area Served
Table 19. Manufacturers Bio-pharma Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Bio-pharma Sales (K Pcs) by Type (2016-2021)
Table 22. Global Bio-pharma Sales Share by Type (2016-2021)
Table 23. Global Bio-pharma Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Bio-pharma Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Bio-pharma Sales Share by Type (2022-2027)
Table 26. Global Bio-pharma Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Bio-pharma Revenue Share by Type (2022-2027)
Table 28. Global Bio-pharma Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Bio-pharma Sales (K Pcs) by Application (2016-2021)
Table 30. Global Bio-pharma Sales Share by Application (2016-2021)
Table 31. Global Bio-pharma Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Bio-pharma Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Bio-pharma Sales (K Pcs) by Application (2022-2027)
Table 34. Global Bio-pharma Sales Share by Application (2022-2027)
Table 35. Global Bio-pharma Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Bio-pharma Revenue Share by Application (2022-2027)
Table 37. Global Bio-pharma Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Bio-pharma Sales (K Pcs) by Company (2016-2021)
Table 39. North America Bio-pharma Sales Market Share by Company (2016-2021)
Table 40. North America Bio-pharma Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Bio-pharma Revenue Market Share by Company (2016-2021)
Table 42. North America Bio-pharma Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Bio-pharma Sales Market Share by Type (2016-2021)
Table 44. North America Bio-pharma Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Bio-pharma Sales Market Share by Type (2022-2027)
Table 46. North America Bio-pharma Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Bio-pharma Sales Market Share by Application (2016-2021)
Table 48. North America Bio-pharma Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Bio-pharma Sales Market Share by Application (2022-2027)
Table 50. Europe Bio-pharma Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Bio-pharma Sales Market Share by Company (2016-2021)
Table 52. Europe Bio-pharma Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Bio-pharma Revenue Market Share by Company (2016-2021)
Table 54. Europe Bio-pharma Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Bio-pharma Sales Market Share by Type (2016-2021)
Table 56. Europe Bio-pharma Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Bio-pharma Sales Market Share by Type (2022-2027)
Table 58. Europe Bio-pharma Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Bio-pharma Sales Market Share by Application (2016-2021)
Table 60. Europe Bio-pharma Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Bio-pharma Sales Market Share by Application (2022-2027)
Table 62. China Bio-pharma Sales (K Pcs) by Company (2016-2021)
Table 63. China Bio-pharma Sales Market Share by Company (2016-2021)
Table 64. China Bio-pharma Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Bio-pharma Revenue Market Share by Company (2016-2021)
Table 66. China Bio-pharma Sales by Type (2016-2021) & (K Pcs)
Table 67. China Bio-pharma Sales Market Share by Type (2016-2021)
Table 68. China Bio-pharma Sales by Type (2022-2027) & (K Pcs)
Table 69. China Bio-pharma Sales Market Share by Type (2022-2027)
Table 70. China Bio-pharma Sales by Application (2016-2021) & (K Pcs)
Table 71. China Bio-pharma Sales Market Share by Application (2016-2021)
Table 72. China Bio-pharma Sales by Application (2022-2027) & (K Pcs)
Table 73. China Bio-pharma Sales Market Share by Application (2022-2027)
Table 74. Japan Bio-pharma Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Bio-pharma Sales Market Share by Company (2016-2021)
Table 76. Japan Bio-pharma Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Bio-pharma Revenue Market Share by Company (2016-2021)
Table 78. Japan Bio-pharma Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Bio-pharma Sales Market Share by Type (2016-2021)
Table 80. Japan Bio-pharma Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Bio-pharma Sales Market Share by Type (2022-2027)
Table 82. Japan Bio-pharma Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Bio-pharma Sales Market Share by Application (2016-2021)
Table 84. Japan Bio-pharma Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Bio-pharma Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Bio-pharma Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Bio-pharma Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Bio-pharma Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Bio-pharma Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Bio-pharma Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Bio-pharma Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Bio-pharma Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Bio-pharma Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Bio-pharma Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Bio-pharma Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Bio-pharma Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Bio-pharma Sales Market Share by Application (2022-2027)
Table 98. India Bio-pharma Sales (K Pcs) by Company (2016-2021)
Table 99. India Bio-pharma Sales Market Share by Company (2016-2021)
Table 100. India Bio-pharma Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Bio-pharma Revenue Market Share by Company (2016-2021)
Table 102. India Bio-pharma Sales by Type (2016-2021) & (K Pcs)
Table 103. India Bio-pharma Sales Market Share by Type (2016-2021)
Table 104. India Bio-pharma Sales by Type (2022-2027) & (K Pcs)
Table 105. India Bio-pharma Sales Market Share by Type (2022-2027)
Table 106. India Bio-pharma Sales by Application (2016-2021) & (K Pcs)
Table 107. India Bio-pharma Sales Market Share by Application (2016-2021)
Table 108. India Bio-pharma Sales by Application (2022-2027) & (K Pcs)
Table 109. India Bio-pharma Sales Market Share by Application (2022-2027)
Table 110. Pfizer Corporation Information
Table 111. Pfizer Description and Business Overview
Table 112. Pfizer Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Pfizer Bio-pharma Product
Table 114. Pfizer Recent Development
Table 115. F. Hoffmann-La Roche AG Corporation Information
Table 116. F. Hoffmann-La Roche AG Description and Business Overview
Table 117. F. Hoffmann-La Roche AG Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. F. Hoffmann-La Roche AG Bio-pharma Product
Table 119. F. Hoffmann-La Roche AG Recent Development
Table 120. Johnson & Johnson Services Corporation Information
Table 121. Johnson & Johnson Services Description and Business Overview
Table 122. Johnson & Johnson Services Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Johnson & Johnson Services Bio-pharma Product
Table 124. Johnson & Johnson Services Recent Development
Table 125. Sanofi, Amgen Corporation Information
Table 126. Sanofi, Amgen Description and Business Overview
Table 127. Sanofi, Amgen Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Sanofi, Amgen Bio-pharma Product
Table 129. Sanofi, Amgen Recent Development
Table 130. AbbVie Corporation Information
Table 131. AbbVie Description and Business Overview
Table 132. AbbVie Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. AbbVie Bio-pharma Product
Table 134. AbbVie Recent Development
Table 135. Merck & Co., Inc Corporation Information
Table 136. Merck & Co., Inc Description and Business Overview
Table 137. Merck & Co., Inc Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. Merck & Co., Inc Bio-pharma Product
Table 139. Merck & Co., Inc Recent Development
Table 140. Biogen Idec Corporation Information
Table 141. Biogen Idec Description and Business Overview
Table 142. Biogen Idec Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Biogen Idec Bio-pharma Product
Table 144. Biogen Idec Recent Development
Table 145. Bayer AG Corporation Information
Table 146. Bayer AG Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. Bayer AG Description and Business Overview
Table 148. Bayer AG Bio-pharma Product
Table 149. Bayer AG Recent Development
Table 150. Eli Lilly and Company Corporation Information
Table 151. Eli Lilly and Company Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. Eli Lilly and Company Description and Business Overview
Table 153. Eli Lilly and Company Bio-pharma Product
Table 154. Eli Lilly and Company Recent Development
Table 155. Novartis AG GlaxoSmithKline Plc Corporation Information
Table 156. Novartis AG GlaxoSmithKline Plc Description and Business Overview
Table 157. Novartis AG GlaxoSmithKline Plc Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. Novartis AG GlaxoSmithKline Plc Bio-pharma Product
Table 159. Novartis AG GlaxoSmithKline Plc Recent Development
Table 160. Bristol-Myers Squibb Company Corporation Information
Table 161. Bristol-Myers Squibb Company Description and Business Overview
Table 162. Bristol-Myers Squibb Company Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 163. Bristol-Myers Squibb Company Bio-pharma Product
Table 164. Bristol-Myers Squibb Company Recent Development
Table 165. AstraZeneca PLC Corporation Information
Table 166. AstraZeneca PLC Description and Business Overview
Table 167. AstraZeneca PLC Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 168. AstraZeneca PLC Bio-pharma Product
Table 169. AstraZeneca PLC Recent Development
Table 170. Abbott Laboratories Corporation Information
Table 171. Abbott Laboratories Description and Business Overview
Table 172. Abbott Laboratories Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 173. Abbott Laboratories Bio-pharma Product
Table 174. Abbott Laboratories Recent Development
Table 175. Production Base and Market Concentration Rate of Raw Material
Table 176. Key Suppliers of Raw Materials
Table 177. Bio-pharma Distributors List
Table 178. Bio-pharma Customers List
Table 179. Bio-pharma Market Trends
Table 180. Bio-pharma Market Drivers
Table 181. Bio-pharma Market Challenges
Table 182. Bio-pharma Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Bio-pharma Product Picture
Figure 2. Global Bio-pharma Sales Market Share by Type in 2021 & 2027
Figure 3. Monoclonal Antibodies Product Picture
Figure 4. Recombinant Proteins Product Picture
Figure 5. Granulocyte-Colony Stimulating Factor (G-CSF) Product Picture
Figure 6. Interferons Product Picture
Figure 7. Recombinant Human Insulin Product Picture
Figure 8. Erythropoietin Product Picture
Figure 9. Vaccines Product Picture
Figure 10. Growth Hormones Product Picture
Figure 11. Purified Proteins Product Picture
Figure 12. Others Product Picture
Figure 13. Global Bio-pharma Sales Market Share by Application in 2021 & 2027
Figure 14. Metabolic Disorders Examples
Figure 15. Oncology Examples
Figure 16. Neurological Disorders Examples
Figure 17. Cardiovascular Diseases Examples
Figure 18. Inflammatory and Infectious Diseases Examples
Figure 19. Others Examples
Figure 20. Global Bio-pharma Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 21. Global Bio-pharma Sales Growth Rate (2016-2027) & (US$ Million)
Figure 22. Global Bio-pharma Sales (K Pcs) Growth Rate (2016-2027)
Figure 23. Global Bio-pharma Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 24. Global Bio-pharma Revenue Market Share by Region: 2016 VS 2021
Figure 25. Global Bio-pharma Revenue Market Share by Region: 2021 VS 2027
Figure 26. North America Bio-pharma Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. North America Bio-pharma Sales (K Pcs) Growth Rate (2016-2027)
Figure 28. Europe Bio-pharma Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. Europe Bio-pharma Sales (Million USD) Growth Rate (2016-2027)
Figure 30. China Bio-pharma Revenue (Million USD) Growth Rate (2016-2027)
Figure 31. China Bio-pharma Sales (Million USD) and Growth Rate (2016-2027)
Figure 32. Japan Bio-pharma Revenue (Million USD) Growth Rate (2016-2027)
Figure 33. Japan Bio-pharma Sales (Million USD) Growth Rate (2016-2027)
Figure 34. Southeast Asia Bio-pharma Revenue (Million USD) Growth Rate (2016-2027)
Figure 35. Southeast Asia Bio-pharma Sales (Million USD) Growth Rate (2016-2027)
Figure 36. India Bio-pharma Revenue (Million USD) Growth Rate (2016-2027)
Figure 37. India Bio-pharma Sales (Million USD) Growth Rate (2016-2027)
Figure 38. Global 5 Largest Bio-pharma Players Market Share by Revenue in Bio-pharma: 2016 & 2020
Figure 39. Bio-pharma Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 40. Global Bio-pharma Revenue Share by Type (2016-2021)
Figure 41. Global Bio-pharma Revenue Growth Rate by Type in 2016 & 2020
Figure 42. Global Bio-pharma Revenue Share by Application (2016-2021)
Figure 43. Global Bio-pharma Revenue Growth Rate by Application in 2016 & 2020
Figure 44. North America Bio-pharma Sales Market Share by Type in 2020
Figure 45. North America Bio-pharma Sales Market Share by Application in 2020
Figure 46. Europe Bio-pharma Sales Market Share by Type in 2020
Figure 47. Europe Bio-pharma Sales Market Share by Application in 2020
Figure 48. China Bio-pharma Sales Market Share by Type in 2020
Figure 49. China Bio-pharma Sales Market Share by Application in 2020
Figure 50. Japan Bio-pharma Sales Market Share by Type in 2020
Figure 51. Japan Bio-pharma Sales Market Share by Application in 2020
Figure 52. Southeast Asia Bio-pharma Sales Market Share by Type in 2020
Figure 53. Southeast Asia Bio-pharma Sales Market Share by Application in 2020
Figure 54. India Bio-pharma Sales Market Share by Type in 2020
Figure 55. India Bio-pharma Sales Market Share by Application in 2020
Figure 56. Key Raw Materials Price Trend
Figure 57. Manufacturing Cost Structure of Bio-pharma
Figure 58. Manufacturing Process Analysis of Bio-pharma
Figure 59. Bio-pharma Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed